Performance of Blood culture, β -D-glucan and PCR for Diagnosis of Systemic Fungal Infection in Cancer Patients

Mohammed Elshaer^1, , Amina Abd El Aal¹, Ahmad Elewa¹ and Noha El-Mashad¹

¹Clinical Pathology Department, Faculty of Medicine, Mansoura, Egypt

Cite this paper:
Mohammed Elshaer, Amina Abd El Aal, Ahmad Elewa and Noha El-Mashad. Performance of Blood culture, β -D-glucan and PCR for Diagnosis of Systemic Fungal Infection in Cancer Patients. American Journal of Microbiological Research. 2019; 7(3):73-77. doi: 10.12691/ajmr-7-3-1

Abstract

Background and purpose: The incidence of systemic fungal infection has increased considerably in recent years. It is of greater concern because they are often misdiagnosed. The study aimed to assess the diagnostic performance of ELISA and Polymerase chain reaction versus the gold standard blood culture in diagnosing systemic fungal infection. Materials and Methods: The study included 70 cancer patients at the Mansoura University Oncology Center clinically suspected to suffer from systemic fungal infection. Blood samples were subjected to automated blood culture, antigen detection by ELISA and PCR for fungal DNA. Results: Considering the different methods used for diagnosis of systemic fungal infection, 19 patients were positive by blood culture, 36 patients were positive by ELISA and 32 patients were positive by PCR. Both β -D-glucan and PCR exhibited higher sensitivity, specificity and accuracy with higher NPV than PPV compared to the gold standard blood culture which lacks the desired sensitivity and specificity. Conclusion: Rapid diagnostic techniques such as ELISA and PCR offer an accurate and reproducible tool for early diagnosis and treatment of fungal pathogens.

Keywords:
blood culture fungi enzyme-linked immunosorbent assay polymerase chain reaction systemic fungal infection

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Falci DR, Stadnik CM, Pasqualotto AC. A review of diagnostic methods for invasive fungal diseases: challenges and perspectives. Infectious diseases and therapy. 2017; 6(2): 213-223.
[2]	Ruhnke M, Böhme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Annals of oncology: official journal of the European Society for Medical Oncology. 2012; 23(4): 823-833.
[3]	Ruhnke M, Schwartz S. Recent developments in the management of invasive fungal infections in patients with oncohematological diseases. Therapeutic advances in hematology. 2016 Dec; 7(6): 345-359.
[4]	Cuenca-Estrella M, Bernal-Martinez L, Buitrago MJ, et al. Update on the epidemiology and diagnosis of invasive fungal infection. International Journal of Antimicrobial Agents. 2008 2008/11/01/; 32: S143-S147.
[5]	Ramanan P, Wengenack NL, Theel ES. Laboratory Diagnostics for Fungal Infections: A Review of Current and Future Diagnostic Assays. Clinics in Chest Medicine. 2017; 38(3): 535-554.
[6]	Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014 Jul; 27(3): 490-526.
[7]	Azab MM, Abo Taleb A, Mohamed NA, et al. Rapid diagnosis of invasive fungal infections. Int J Curr Microbiol App Sci. 2015; 4: 470-486.
[8]	Ramos JT, Villar S, Bouza E, et al. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study). Journal of Clinical Microbiology. 2017; 55(9): 2752-2764.
[9]	Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. Journal of clinical microbiology. 2011; 49(2): 665-670.
[10]	De Pauw B, Walsh TJ, Donnelly JP, et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases. 2008; 46(12): 1813-1821.
[11]	Alexander BD, Smith PB, Davis RD, et al. The (1, 3) β-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. Journal of clinical microbiology. 2010; 48(11): 4083-4088.
[12]	Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida Real-time Polymerase Chain Reaction, β-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis. Clinical Infectious Diseases. 2012; 54(9): 1240-1248.
[13]	Wagner K, Springer B, Pires VP, et al. Molecular detection of fungal pathogens in clinical specimens by 18S rDNA high-throughput screening in comparison to ITS PCR and culture. Scientific Reports. 2018 2018/05/03; 8(1): 6964.